Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy

Jason R. Gee, Daniel R. Saltzstein, Edward Messing, Kyung Mann Kim, Jill Kolesar, Wei Huang, Thomas C. Havighurst, Linda Harris, Barbara W. Wollmer, David Jarrard, Margaret House, Howard Parnes, Howard H. Bailey

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science